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ABSTRACT  
   
Wearable robots including exoskeletons, powered prosthetics, and powered 
orthotics must add energy to the person at an appropriate time to enhance, augment, or 
supplement human performance. Adding energy while not being in sync with the user can 
dramatically hurt performance making it necessary to have correct timing with the user. 
Many human tasks such as walking, running, and hopping are repeating or cyclic tasks 
and a robot can add energy in sync with the repeating pattern for assistance. A method 
has been developed to add energy at the appropriate time to the repeating limit cycle 
based on a phase oscillator. The phase oscillator eliminates time from the forcing 
function which is based purely on the motion of the user. This approach has been 
simulated, implemented and tested in a robotic backpack which facilitates carrying heavy 
loads. The device oscillates the load of the backpack, based on the motion of the user, in 
order to add energy at the correct time and thus reduce the amount of energy required for 
walking with a heavy load. Models were developed in Working Model 2-D, a dynamics 
simulation software, in conjunction with MATLAB to verify theory and test control 
methods. The control system developed is robust and has successfully operated on a 
range of different users, each with their own different and distinct gait. The results of 
experimental testing validated the corresponding models. 
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CHAPTER 1 
INTRODUCTION 
Soldiers are routinely required to carry between 60-100 pounds of gear including 
body armor, weapons, ammo and batteries [1-2]. Carrying this excessive weight while 
running, jumping and other various activities causes strain on the lumbar. Only 13% of 
soldiers evacuated due to back pain return to active duty [3]. There is a need for a device 
that can alleviate the pains associated with carrying heavy loads.  
The development of exoskeletons to add energy to the human user is a growing 
field of interest. Exoskeletons can assist users in a variety of situations whether they be 
rehabilitation, joint torque assistance or load carrying assistance. Companies such as 
Google, Lockheed Martin, Raytheon and Honda are currently developing and improving 
such exoskeletons.  
In this research, the objective is to develop an exoskeleton that can facilitate load 
carrying by reducing the energy required to walk with heavy loads. The ultimate goal is 
to allow the user to walk further and faster than they could otherwise do without the 
device.  
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CHAPTER 2 
BACKGROUND 
Wearable robots including exoskeletons, powered prosthetics, and powered 
orthotics must add energy to the person at an appropriate time to enhance, augment, or 
supplement human performance. Adding energy while not being in sync with the user can 
dramatically hurt performance making it is necessary to have correct timing with the user. 
Many human tasks such as walking, running, and hopping are repeating or cyclic tasks 
and the robot must add energy in sync with the repeating cycle.  
To be able to add energy to the gait cycle it is important to understand the 
different stages in the gait cycle and how the body moves over time. It has been shown 
that the human moves up and down a span of approximately two inches [4-5]. By 
understanding when muscles are being activated and whether they are in concentric or 
eccentric contraction is important because it has been shown that muscles that are 
eccentrically contracted can produce three to six times the amount of work of the same 
muscles concentrically contracted [6]. 
Armed with this knowledge, one can begin to understand when energy can be 
added to the gait cycle that will benefit the user and not harm them. The University of 
California at Berkeley has developed an exoskeleton that transfers backpack loads to the 
ground making it easier to carry heavy loads [7-8]. Harvard, Massachusetts Institute of 
Technology and Arizona State University have functioning exoskeletons that are adding 
energy to the user by adding torque to the user’s joints [9-11]. Kerestes at Arizona State 
uses a phase oscillator controller and pneumatic actuators to add torque to the user’s hips 
[12]. Rate gyros are placed on the thighs which measure angular velocity which can be 
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integrated to a relative angle. A phase angle, described in detail in Chapter 3, is used to 
trigger actuators which add torque to the user’s hips. This device was taken to the Army 
Research Laboratory where two subjects wore the device. The device was too large for 
the first subject and showed a metabolic increase with the device on versus no device at 
all. The device was a better fit for the second subject and was able to reduce metabolic 
cost by 8% for running at 6mph and by 10.2% at 8mph. This device achieved metabolic 
augmentation. 
Kerestes also developed an initial Pogo Suit to assist with human running [13]. 
The device used a small secondary mass that oscillated while the human ran or hopped to 
add energy and reduce metabolic cost. This device showed an increase in hop height of 
approximately four inches. Initial testing did not indicate metabolic augmentation but 
allowed the user to carry the additional weight of the device, approximately 10 pounds, 
with no additional cost. The device was able to overcome its weight but no more. 
This device is the basis for the mechanical design of the device developed in this 
paper. The researcher will apply the principles in loaded walking in the place of running, 
using the load of the backpack mass as the secondary oscillating mass. 
The control method used to control the device discussed in this paper is called a 
phase oscillator. Other groups use different forms of oscillators to control exoskeletons. 
Rinderknecht et al. use a phase angle to estimate joint angles, velocities and accelerations 
in order to provide an assistive torque to human elbow movements [14]. Using a 
modified adaptive oscillator developed by Righetti [15] and a position sensor, they are 
able to extract estimates of the fundamental frequency, amplitude and phase shift from 
the elbow motion. These are the inputs to a system loop which estimates the elbow’s 
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current state and adds a corresponding assistive torque, see Figure 2.1.  The results on 
two subjects showed that the exoskeleton was able to get in phase with the user in 
approximately 10 cycles [14]. 
 
Figure 2.1:  Block diagram of human and exoskeleton system developed by 
Rinderknecht et al. [14] 
The approach described in this thesis adds energy to the user by applying a force 
from a secondary mass at the correct time during gait by means of a phase oscillator 
controller. 
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CHAPTER 3 
PHASE OSCILLATOR 
A general equation for a mechanical system is described by a 2nd order system 
with a given mass, m, damping, b, and stiffness, k. 
𝑚?̈? + 𝑏?̇? + 𝑘𝑥 = 0 (3.1)  
𝑥 = −𝐴 𝑐𝑜𝑠 𝜔𝑡 (3.2) 
?̇? = 𝐴𝜔𝑠𝑖𝑛 𝜔𝑡 (3.3) 
?̈? = 𝐴𝜔2𝑐𝑜𝑠 𝜔𝑡 (3.4) 
The frequency of oscillations of the system modeled by equation 3.1 is dependent on the 
mass, 𝑚, and the spring constant, 𝑘. The behavior of the amplitude of the oscillations is 
dependent on the damping coefficient, 𝑏. If 𝑏 > 0, the system has positive damping, and 
the oscillations will shrink and disappear over time. If 𝑏 < 0, the system has negative 
damping, and the oscillations will continue to grow. If 𝑏 = 0, the system has no damping, 
and the oscillations will remain at a constant amplitude. A “phase oscillator method” 
cancels the damping of the system to create a limit cycle and is based on the phase plane 
of the system. The method adds energy to the system based on the phase angle, 𝜙, shown 
in Figure 3.1. 
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Figure 3.1:  Phase angle is defined as 𝑎𝑡𝑎𝑛2(?̇?, 𝑥) 
 
The phase angle can be used to determine when to add energy to the system and 
how much energy to add. Figure 3.2 shows the phase plot for the case where 𝑏 = 0, and 
Figure 3.3 shows the phase angle over time. 
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Figure 3.2:  Phase plot of an oscillating system with no damping. 𝑚 = 1 kg, 𝑘 = 50 
N/m, 𝑏 = 0 Ns/m, initial position = 1 m, initial velocity = 0 m/s 
 
Figure 3.3:  Phase angle of an oscillating system with no damping. 
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With the first definition of the phase angle, the phase angle remains close to ±
𝜋
2
 
for the majority of each oscillation, despite the smooth oscillations. This is because the 
velocities are almost an order of magnitude higher than the positions which causes the 
phase plot, if plotted on the same scale, to be more elliptical rather than circular.  When 
the velocity is divided by the natural frequency, 
(
?̇?
𝜔
)
𝑥
 becomes unitless, the phase plot 
becomes a perfect circle and the phase angle becomes linear as seen in Figures 3.4 and 
3.5.  
𝜔 = √
𝑘
𝑚
   (3.5) 
𝜙 = 𝑎𝑡𝑎𝑛2 (
?̇?
𝜔
, 𝑥) (3.6) 
 
Figure 3.4:  Phase plot of an oscillating system with the velocity divided by the natural 
frequency. 
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Figure 3.5:  Phase angle when velocity is divided by the natural frequency. 
 
A forcing function proportional to the sine of the phase angle can be used to add 
energy to the system. The forcing function puts the system into a limit cycle by canceling 
the damping term. Equation 3.7 models the system with the phase oscillator. 
𝑚?̈? + 𝑏?̇? + 𝑘𝑥 = 𝑐 sin 𝜙 (3.7) 
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Figure 3.6:  Spring response with phase oscillator. 𝑚 = 1 kg, 𝑏 = 1 Ns/m, 𝑘 = 50 N/m, 
c = 20, initial position = 1 m, initial velocity = 0 m/s. 
 
Figure 3.7:  Spring response with phase oscillator. 𝑚 = 1 kg, 𝑏 = 1 Ns/m, 𝑘 = 50 N/m, 
c = 20, initial position = 6 m, initial velocity = 0 m/s. 
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When implementing a negative damping control method in a 2nd order system, 
the value for the negative damping must perfectly match the linear damping term for the 
system to achieve oscillatory behavior. This is implemented simply in simulations but is 
difficult to achieve empirically. When oscillatory behavior is achieved experimentally, it 
is highly dependent on initial conditions. Figures 3.6 and 3.7 show that using the phase 
oscillator controller the system will achieve steady state independent of the initial 
conditions [16]. This limit cycle can be found by solving equation 3.7 analytically. 
Substituting equation 3.8 into equation 3.7 determines a sinusoidal solution given by 
equation 3.9. The amplitude, 𝐴, of the solution is given by equation 3.10. 
sin 𝜙 =
(
?̇?
𝜔
)
√(
?̇?
𝜔
)
2
+𝑥2
        (3.8) 
𝑥(𝑡) = 𝐴 sin(𝜔𝑡) (3.9) 
𝐴 =
𝑐
𝑏𝜔
=
𝑐√𝑚
𝑏√𝑘
  (3.10) 
Using the phase oscillator control method, the amplitude of the system can be changed 
directly by adjusting  𝑐. 
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CHAPTER 4 
POGO PRINCIPLES 
 
Walking is a repeating or cyclical task which provides an ideal platform to use a 
phase plane based control approach to add energy to the human. As a person walks, the 
vertical motion of the trunk appears to be almost sinusoidal but because there is a 
moment when both feet are on the ground, the trunk acceleration is not sinusoidal but has 
a ‘double bump’ caused by the opposite foot hitting the ground as seen in Figure 4.1 [4]. 
By integrating the accelerometer data twice to achieve position, it can be argued that the 
position of the human closely resembles a sinusoidal signal so the assumption of 
sinusoidal motion for modeling purposes can be justified.  
 
Figure 4.1:  Acceleration and position signal of subject walking on treadmill at 3mph 
showing that the human’s COM position can be assumed to be sinusoidal. 
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By assuming the vertical motion of the trunk to be sinusoidal, position, 𝑥ℎ , 
velocity, ?̇?ℎ , and acceleration, ?̈?ℎ , can be defined in the same way as in the previous 
modeling shown in equations 3.2 - 3.4. Using Working Model 2D, a dynamics simulation 
software, a human with mass, 𝑚ℎ , can be modeled as a 2nd order system mass-spring-
damper system with a linear actuator creating the trunk’s sinusoidal motion[17-21]. A 
back pack can be modeled by adding a mass, 𝑚𝑝 , pinned to the trunk, as seen in Figure 
4.2. The human motion is simulated using a position controlled actuator attached to the 
trunk, a 73 kilogram mass. The pack is attached to the trunk and has a mass of 27 kg. 
Working Model allows the user to add forces, actuators, motors and other modeling tools 
to create a specific dynamic system. 
 
Figure 4.2:  Working Model 2D model of human trunk with a linear actuator to simulate 
vertical motion. 
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  The linear actuator is driven with a position command of 𝑥 = −0.0254cos 𝑤𝑡 to 
simulate the trunk oscillating with a magnitude of one inch [5]. Working Model allows 
the user to ‘monitor’ different parameters, typically displayed as a graph, of the modeled 
system in order to visualize the dynamics. The power of the actuator can be monitored in 
order to understand the energy involved forcing the trunk up and down. A successful 
exoskeleton to assist with load carrying would add positive power at all times thus 
reducing the power required by the legs, or actuator in the case of the model, to move the 
trunk. 
 
 
Figure 4.3:  Working Model 2D model of human trunk with a linear actuator to simulate 
vertical motion and an added force. 
 
A force based on the sine of the phase angle can be added to this gait model 
which pushes the center of mass, COM, up as it moves up and pushes down as the COM 
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moves down, seen in Figure 4.3. Figure 4.4 gives a visual of when the force acts during 
the gait cycle. Using Working Model 2D it can be shown that this forcing function 
reduces the powers needed for walking.  
 
Figure 4.4:  The forcing function based on the sine of the phase angle pushes up as the 
COM moves up and pushes down as the COM moves down. 
 
To validate the theory, a force based on the phase angle, 𝑓 = 100𝑠𝑖𝑛𝜙, is applied 
to the trunk. Potential metabolic savings can be estimated by monitoring the actuator 
power required to oscillate the trunk with no force versus with an applied force, 𝑓. The 
results of this simulation are shown in Figure 4.5. We can see that the positive power 
peak are reduced but the negative power peaks are increased. Research has shown that 
concentric muscle contractions require three to six times more energy to produce the 
same amount of work as eccentric muscle contractions [6]. The argument can be made 
that the increased negative power peaks are easier for the human to absorb in the walking 
gait because the required muscles are eccentrically contracting until roll over where they 
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begin to concentrically contract. Using that knowledge, the benefit in the reduction of 
positive power peaks will have more impact on the user than the addition of increased 
negative power peaks because of where they happen in the gait cycle. 
 
Figure 4.5:  Positive power peaks required to oscillate the human are reduced and 
negative power peaks are increased. 
 
  17 
CHAPTER 5 
POGO SUIT SIMULATIONS 
The pogo suit uses a secondary mass that is linearly displaced resulting in a 
reaction force on the user opposite the mass’ acceleration.  This is modeled in Working 
Model by adding a second linear actuator that is attached to the backpack at one end and 
another mass at the other as seen in Figure 5.1. 
 
Figure 5.1:  Working Model 2D model of human trunk with pogo suit actuator modeled 
in the backpack as a secondary mass on a linear actuator. 
 
From the previous force model, the desired additional forcing function is a pure 
force based on the sine of the phase angle. In this case, the force, 𝑓, is negative because 
the pogo suit applies a force to the user based on a reaction force. Solving the basic 
dynamic equations gives an expression for the acceleration of the pogo suit mass, which 
can be integrated to find the position of the mass to deliver the desired force.  
𝑓 = 𝑓𝑜sinϕ                    (5.1) 
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𝑚𝑙𝑜𝑎𝑑(?̈?ℎ + ?̈?𝑝𝑜𝑔𝑜) = −𝑓𝑜 sin 𝜙       (5.2) 
?̈?𝑝𝑜𝑔𝑜 =
−𝑓𝑜
𝑚𝑙𝑜𝑎𝑑
𝑠𝑖𝑛𝜙 − ?̈?ℎ        (5.3) 
?̈?𝑝𝑜𝑔𝑜 =
−𝑓𝑜
𝑚𝑙𝑜𝑎𝑑
𝑠𝑖𝑛𝜙 − 𝐴𝜔2cos 𝜔𝑡       (5.4) 
𝑥𝑝𝑜𝑔𝑜 =
𝑓𝑜
?̇?2𝑚𝑙𝑜𝑎𝑑
𝑠𝑖𝑛𝜙 + 𝐴cos 𝜔𝑡       (5.4) 
The subscript, h, represents the motion of the human.  The subscript, pogo, 
represents the motion of the oscillatory, secondary mass.  The position equation for the 
pogo suit, 𝑥𝑝𝑜𝑔𝑜, has a term that is related to time which comes from the ?̈?ℎ term in the 
equation 5.2. By looking at the definition of the phase angle we can develop an 
expression for 𝑐𝑜𝑠𝜔𝑡 in terms of the phase angle, 𝜙, and eliminate time from the 
equation, see equations 5.5 – 5.7. This is significant because the control signal will then 
only depend on the motion of the human’s COM and be independent of time. Table 5.1 
shows that independent of the definition of the human position, 𝑥ℎ , the portion of the 
pogo suit position related to the human acceleration and time is equal to – 𝑐𝑜𝑠𝜙 . 
√(
?̇?
𝜔
)
2
+ 𝑥2 = √𝐴2(cos(𝜔𝑡))2 + 𝐴2(sin(𝜔𝑡))2 = 𝐴      (5.5) 
𝑐𝑜𝑠𝜙 =
𝑥ℎ
√(
?̇?ℎ
𝜔
)
2
+𝑥ℎ
2  
=
𝑥ℎ
𝐴
= −
𝐴𝑐𝑜𝑠𝜔𝑡
𝐴
= −𝑐𝑜𝑠𝜔𝑡           (5.6) 
sin 𝜙 =
?̇?ℎ
𝜔
√(
?̇?ℎ
𝜔
)
2
+𝑥ℎ
2
=
𝐴 sin(𝜔𝑡)
𝐴
= sin(𝜔𝑡)           (5.7) 
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𝑃𝑜𝑠𝑖𝑡𝑖𝑜𝑛 𝑥ℎ = 𝐴𝑐𝑜𝑠𝜔𝑡 𝑥ℎ = 𝐴𝑠𝑖𝑛𝜔𝑡 
𝑥ℎ
= −𝐴𝑐𝑜𝑠𝜔𝑡 
𝑥ℎ = −𝐴𝑠𝑖𝑛𝜔𝑡 
𝑉𝑒𝑙𝑜𝑐𝑖𝑡𝑦 
?̇?ℎ
= −𝐴𝜔𝑠𝑖𝑛𝜔𝑡 
?̇?ℎ = 𝐴𝜔𝑐𝑜𝑠𝜔𝑡 
?̇?ℎ
= 𝐴𝜔𝑠𝑖𝑛𝜔𝑡 
?̇?ℎ = −𝐴𝜔𝑐𝑜𝑠𝜔𝑡 
𝐴𝑐𝑐𝑒𝑙𝑒𝑟𝑎𝑡𝑖𝑜𝑛 
?̈?ℎ
= −𝐴𝜔2𝑐𝑜𝑠𝜔𝑡 
?̈?ℎ
= −𝐴𝜔2𝑠𝑖𝑛𝜔𝑡 
?̈?ℎ
= 𝐴𝜔2𝑐𝑜𝑠𝜔𝑡 
?̈?ℎ = 𝐴𝜔
2𝑠𝑖𝑛𝜔𝑡 
𝑠𝑖𝑛𝜙 −𝑠𝑖𝑛𝜔𝑡 𝑐𝑜𝑠𝜔𝑡 𝑠𝑖𝑛𝜔𝑡 −𝑐𝑜𝑠𝜔𝑡 
𝑐𝑜𝑠𝜙 𝑐𝑜𝑠𝜔𝑡 𝑠𝑖𝑛𝜔𝑡 −𝑐𝑜𝑠𝜔𝑡 −𝑠𝑖𝑛𝜔𝑡 
𝜙 −𝜔𝑡 −𝜔𝑡 +
𝜋
2
 −𝜔𝑡 + 𝜋 −𝜔𝑡 −
𝜋
2
 
?̈?ℎ 𝑡𝑒𝑟𝑚 𝑖𝑛 𝑥𝑝𝑜𝑔𝑜  −𝐴𝑐𝑜𝑠𝜔𝑡 −𝐴𝑠𝑖𝑛𝜔𝑡 𝐴𝑐𝑜𝑠𝜔𝑡 𝐴𝑠𝑖𝑛𝜔𝑡 
?̈?ℎ  𝑡𝑒𝑟𝑚 𝑖𝑛 𝑥𝑝𝑜𝑔𝑜  
𝑖𝑛 𝑡𝑒𝑟𝑚𝑠 𝑜𝑓 𝜙 
−𝑐𝑜𝑠𝜙 − cos 𝜙 −𝑐𝑜𝑠𝜙 −𝑐𝑜𝑠𝜙 
 
Table 5.1:  Each definition for the position of the COM results in the human acceleration 
term being equivalent to−𝑐𝑜𝑠𝜙. 
 
From this we have a complete solution for the position of our secondary mass 
which will achieve the desired force, defined purely by the phase angle of the user’s 
trunk. The multipliers on the sinusoidal functions simply scale the amplitude of the 
combined sinusoid that is shown in equations 5.8 – 5.13. This shows that the amplitude of 
the force is changed by simply changing the amplitude of the secondary mass’ position 
function. 
 
𝑥𝑝𝑜𝑔𝑜 =
𝑓𝑜
?̇?2𝑚𝑙𝑜𝑎𝑑
𝑠𝑖𝑛𝜙 − 𝐴cos 𝜙       (5.8) 
𝑙𝑒𝑡 𝑎 =
𝑓𝑜
?̇?2𝑚𝑙𝑜𝑎𝑑
 𝑎𝑛𝑑 𝑏 = 𝐴        (5.9) 
  20 
𝑎𝑠𝑖𝑛𝜙 − 𝑏𝑐𝑜𝑠𝜙 ≡ 𝑅𝑐𝑜𝑠𝛼𝑠𝑖𝑛𝜙 − 𝑅𝑠𝑖𝑛𝛼𝑐𝑜𝑠𝜙 ≡ 𝑅𝑠𝑖𝑛(𝜙 − 𝛼)   (5.10) 
𝑡𝑎𝑛𝛼 =
𝑏
𝑎
 ∴ 𝛼 = atan2(b, a)         (5.11) 
𝑅 = √𝑎2 + 𝑏2       (5.12) 
𝑥𝑝𝑜𝑔𝑜 = 𝑅𝑠𝑖𝑛(𝜙 − 𝛼)       (5.13) 
By choosing the amplitude, 𝑎, of both the 𝑠𝑖𝑛𝜙 and 𝑐𝑜𝑠𝜙 terms to be the same, 𝛼 
is then equal to 
𝜋
4
. Each user will then be able to choose the amount of force preferred by 
choosing the amplitude of the pogo position. 
Figures 5.2 and 5.3 show the simulated position of the trunk and actuator and the actuator 
position for 𝑥𝑝𝑜𝑔𝑜 = 0.0254 sin (𝜙 −
𝑝𝑖
4
). 
 
Figure 5.2:  Working Model 2D simulation of the trunk and pogo actuator position for 
the derived position found in eq. 5.10 
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Figure 5.3:  Simulated powers required to oscillate trunk with and without pogo suit 
device. 
 
Once the Working Model 2D model was created and being driven by MATLAB, 
it was simple to try other potential control methods. Figures 5.4 and 5.5 show 𝑥𝑝𝑜𝑔𝑜 =
𝑐𝑜𝑠𝜙 which if the amplitude matches the amplitude of the user would completely cancel 
the motion of the user and the load would not appear to be moving.  Simulation shows 
that positive and negative powers are increased substantially meaning this might feel 
awful to the user. 
  22 
 
Figure 5.4:  Working Model 2D simulation of the trunk and pogo actuator position for 
𝑥𝑝𝑜𝑔𝑜 = 𝑐𝑜𝑠𝜙. 
 
Figure 5.5:  Simulated powers for  𝑥𝑝𝑜𝑔𝑜 = 𝑐𝑜𝑠𝜙. 
 
Because 𝑐𝑜𝑠𝜙 showed almost the complete opposite of the desired powers, 
−𝑐𝑜𝑠𝜙 should give the desired powers. Figures 5.6 - 5.7 show the simulated positions 
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and powers which appear to be a good. Another way to get these same results is to take 
the accelerometer signal, apply a low pass filter, scale it to the desired amplitude and 
send that signal as the position command of the pogo device.  This method is simpler but 
might not work because of the double bump in the acceleration signal seen in Figure 4.1. 
 
Figure5.6:  Working Model 2D simulation of the trunk and pogo actuator position for 
−𝑐𝑜𝑠𝜙. 
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Figure 5.7:  Simulated powers for  −𝑐𝑜𝑠𝜙 
 
Figures 5.8 and 5.9 show simulations of 𝑥𝑝𝑜𝑔𝑜 = 𝑠𝑖𝑛𝜙. It is unclear whether this 
command would help or hurt the user’s performance based on the power curve. 
 
Figure 5.8:  Working Model 2D simulation of the trunk and pogo actuator position for 
𝑥𝑝𝑜𝑔𝑜 = 𝑠𝑖𝑛𝜙. 
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Figure 5.9:  Simulated powers for 𝑥𝑝𝑜𝑔𝑜 = 𝑠𝑖𝑛𝜙. 
 
The position command of – 𝑠𝑖𝑛𝜙 was also simulated and again is not clear by the power 
curve whether this will help or hurt the user. 
 
Figure 5.10:  Working Model 2D simulation of the trunk and pogo actuator position for 
– 𝑠𝑖𝑛𝜙. 
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Figure 5.11:  Simulated powers for – 𝑠𝑖𝑛𝜙. 
 
Adding energy to a human through an exoskeleton needs to be timed perfectly or 
else the device could dramatically hurt the performance of the human. After the 
simulations are complete, it is important to validate the results of the simulations and 
physically understand how each of the control methods feels to the user. From there, it is 
possible to eliminate bad control methods and focus on improving methods that feel 
good. 
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CHAPTER 6 
POGO SUIT IMPLEMENTATION 
Using a control method based on the phase angle of the user requires the system 
to have the position and the velocity of the COM of the user. This can be achieved by 
collecting an acceleration signal from the user and integrating once to get velocity and 
twice to get position. This can prove to be a problem due to integral drift unless a pseudo-
integrator is used, seen in equations 6.1 - 6.2. 
𝑆𝑖𝑛𝑔𝑙𝑒 𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑜𝑟 ⇒  
𝑠
(𝑠+𝜏)2
       (6.1) 
𝐷𝑜𝑢𝑏𝑙𝑒 𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑜𝑟 ⇒
𝑠
(𝑠+𝜏)3
       (6.2) 
 Dr. Matthew Holgate uses this pseudo integrator in control of a transtibial prosthesis. 
“The principal desirable property of the pseudo-integration method is the 
removal of integration drift. It can be seen that for frequencies smaller 
than 𝜏 the transfer function attenuates the input. The drift that occurs is in 
this frequency range and is thus attenuated. An integrator has a pole on 
the imaginary axis, which makes it marginally stable and there for the 
output is able to drift. The pseudo-integration transfer function has two 
stable poles, which eliminate the drift. By choosing  𝜏 one can choose how 
fast the poles are. This has the effect of constantly pulling the output 
toward the input, which is the angular velocity. Since the angular velocity 
is always centered around zero, the pseudo-angle will also be 
approximately centered around zero, it is stable and attracted to the 
input.”[22]  
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Figure 6.1:  Bode plots for pseudo-integrator transfer function and integrator [22] 
 
With position and velocity signals that center around zero, a phase plane can be 
developed and a phase angle extracted. Figures 6.2 - 6.4 show the acceleration, velocity 
and position signals of a subject walking on a treadmill at three miles per hour and the 
corresponding phase plane, and the phase angle, 𝜙. It can be seen that the phase plane is 
not perfectly circular causing the resulting phase angle not to be perfectly linear. This in 
turn will cause the sinusoidal position signals to be imperfect. 
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Figure 6.2:  Human acceleration, velocity and position signals used to control the pogo 
suit. 
 
Figure 6.3:  Phase plane of subject walking on a treadmill at 3mph. 
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Figure 6.4:  Phi versus time for a human subject walking at 3mph. 
 
The actual device is made up of a DC motor, lead screw, and linear carriage on a 
military grade pack. The device is powered by a 6 cell lithium polymer battery and 
weighs approximately eight lbs. The device uses a Digilent Cerebot MC7 board with a 
Microchip dsPIC33FJ128MC706A as the microcontroller to read in accelerometer and 
encoder signals and send out motor position commands. The C code was developed using 
MATLAB and Simulink in conjunction with Simulink Coder which takes a Simulink 
model and converts it to C. The code is then compiled and programmed to the 
microprocessor using MPLAB. Using this method of writing and building code allows 
the designer to quickly write and test controls. Having simulated a variety of control 
functions, it was easy to check whether they felt like they were assisting or hurting the 
user by simply changing the program slightly to reflect the desired control. Three 
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different users tried each control method with the device oscillating 30 pounds and gave 
feedback which will be summarized.  
 
Figure 6.5:  Pogo Suit physical device. 
 
Figure 6.6 shows the derived and simulated control position of  xpogo =
0.0254 sin (ϕ-
π
4
). Appendix B contains side by side comparisons of each of the 
simulated control signals with actual control signals. This control method felt the best. 
Intuitively one can look at the position curves and see that when the user reaches the 
lowest point in the gait, heel strike, the device is accelerating down, giving an upward 
force. This makes the weight of the pack feel lighter and relieves the leg muscles. When 
walking with the device on for a minute and then turning it off, it is easy to feel that the 
device is adding energy to the user at the right times making it feel better to walk with the 
heavy load. 
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Figure 6.6:  Simulated (left) versus actual (right) human and pogo suit position for 
𝑥𝑝𝑜𝑔𝑜 = 0.0254 sin (𝜙 −
𝜋
4
).  
 
Even though the device ‘feels good’ to the user, it is necessary to verify the 
feeling with empirical data. There must be either a metabolic augmentation or else an 
increase in walking speed in order to justify the added weight of the device to the pack. A 
set of experiments was developed to determine the effectiveness of the device and 
whether or not the device could overcome its weight. To comply with Arizona State 
University’s human subject testing guidelines a testing protocol was developed, reviewed 
and approved by their Internal Review Board, IRB. All documents relating to the IRB 
submission and approval can be found in Appendix A. 
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CHAPTER 7 
TESTING AND RESULTS 
The testing protocol that follows was used to collect and analyze data. Before any 
physical tests were conducted, the subject was provided an opportunity to gain familiarity 
with the device. Basic training on the operation of the device and user controls was 
administered by one of the research team members. The subject was allowed to gain 
familiarity while walking at their own set pace. This training session included step-by-
step instructions covering the basic operation of the device; controlling the device while 
it is on and turning it off. Device training consisted of a 10 minute information session in 
the robotics lab on how the device works, what to expect and how to use the controls.  
After the subject was comfortable with the device, the testing commences first on the 
treadmill. The tests listed below are not randomized, but in order to insure independent 
results, statistical software was used which randomized trials and levels. The subject was 
allowed to rest 10-15 minutes before performing four tests on the treadmill. 
 Test subjects first walked 800 meters at 3mph with the device turned off with a 
22lb payload (to account for the weight of the device) and then were allowed to 
rest 10-30 minutes depending on subject’s stamina. 
 Test subjects then walked 800 meters at 3mph with the device turned on with a 
30lb payload and then were allowed to rest 10-30 minutes depending on stamina. 
 If and only if the subjects felt able to do so, the previous two tests were repeated 
with 10-30 minute breaks between them. 
 Subjects wore a heart rate monitor and a V02 mask 
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 Resting heart rate and resting V02 rate were collected before each of the 4 trials.  
This resting V02 rate set the baseline for each trial. 
The subject then had the opportunity to rest a minimum of half an hour up to an hour 
and then went outside to do over ground testing.  Again, the trials as presented are not 
randomized but were when the subject performed them. There will be the same 4 tests 
performed. 
 Test subjects first walked 800 meters at 3mph with the device turned off with a 
22lb payload (to account for the weight of the device) and then were allowed to 
rest 10-30 minutes depending on subject’s stamina. 
 Test subjects then walked 800 meters at 3mph with the device turned on with a 
30lb payload and then were allowed to rest 10-30 minutes depending on stamina. 
 If and only if the subjects felt able to do so, the previous two tests were repeated 
with 10-30 minute breaks between them. 
 For each test, a heart rate monitor and a GPS watch was worn to measure heart 
rate, speed, and time during the test. 
While performing all tests, the subjects were be monitored for their heart rate via a 
wireless Bluetooth heart rate wrist watch. For over ground testing, the watch will also 
track subjects speed and distance walked. If the subject is comfortable and able, we will 
repeat the tests to get more iterations. 
The results of one subject’s metabolic tests of the device on with 30 pounds and 
the device off with 22 pounds were analyzed using Minitab as seen in Table 7.1. The 
results showed that difference between the metabolic outputs are statistically significant 
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using a 95% confidence level. With a p-value of much less than 0.001 it is shown that the 
device causes a statistically significant increase in the metabolic output. 
 
Table 7.1:  Minitab output for a two-sample T test of one subjects metabolic tests.  
 
Table 7.2 shows the results of a subject walking with no load, 22 and 30 pounds 
with the device off, and 30 pounds with the device on. By looking at the average 
metabolic cost during the trial, it can be shown that the main increase in metabolic cost is 
due to the additional weight of the device, 8 pounds. When comparing the data for 30 
pounds with the device on versus off using a two sample t-test, the resulting p-value is 
0.86 which shows that there is no statistical difference between the trials. This means that 
the device is not helping, but it also means that the device is not hurting. More tests will 
be performed in future work to verify the results found in this trial. 
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Table 7.2:  Metabolic results for one subject with no load, 22 lbs, 30 lbs and 30 lbs 
oscillating based on the phase angle.  
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CHAPTER 7 
CONCLUSION AND FUTURE WORK 
A method for adding energy to the human gait based on the user’s phase angle has 
been developed, implemented and tested. A physical system was built and controls 
developed using Simulink in conjunction with Simulink Coder. The device was tested 
with several control methods to determine which method felt best to the user. With this 
control method, metabolic data was collected for the device off with a 22 pound load 
versus the device on with a 30 pound load. The difference in load is to account for the 
device weight. By performing a two sample T test, there was a statistical difference when 
carrying 22 pounds versus 30 pounds when looking at oxygen consumption.  There was 
not a statistical difference between carrying 30 pounds with the device turned on versus 
turned off when looking at oxygen consumption. The device weight of eight pounds was 
too significant  
Metabolic augmentation is possible with future work. The team will continue to 
test the Pogo Suit device with more users to verify results of the one subject’s results in 
discussed. The performance of an exoskeleton can be user dependent which could mean 
that other users could show better results.  
The mechanical system was built with parts on hand and not specifically designed 
for the task. The lead screw and nut provided a lot of friction for the motor to overcome 
and the motor speed and torque were not optimal resulting in excess heat generated. This 
heat caused the linear system to drift due to the encoder getting too hot. If the motor is 
geared correctly, its efficiency will go up and reduce the heat generated most likely to a 
temperature level suitable for the encoder. With a linear system geared for this 
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application more weight could be added to the system which could help to overcome the 
device. It could be that the eight pound weight of the device was too significant of a 
percentage of the payload weight for there to be benefit of carrying the added weight. By 
reducing the weight of the device and designing the motor carriage system for heavy 
loads could improve the system. The device weight would be less significant if the 
payload weight were 80-100 pounds in which case the potential benefit could be more 
apparent. 
Another study could be done on load placement. Currently the load is two thirds 
of the way up the user’s back where having the mass closer to the user’s hip may be 
beneficial. Studies have been done on load placement in packs which have shown that 
when both loads placed high on the back and low on the back cause the user to lean 
forward as to bring the total center of mass over their feet. Lower loads cause more strain 
because the body needs to rotate more to move the center of mass over the feet, but high 
loads increase dynamic moments which causes stability issues with the user [23]. It 
would be interesting to see the effect of lowering the load closer to the waist of the user. 
A study can also be done on the phase shift, 𝛼, to find the optimal phase shift to 
decrease metabolic cost. A response curve can be developed for different phase shifts 
making it possible to find the value that yields the lowest metabolic cost. The current 
system is using a 45 degree phase shift which was chosen because of simplicity but could 
possibly not be the optimal solution. 
Using hydraulic actuators is another method that could mitigate the issue of 
adding more weight because hydraulics can handle much higher loads. 
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APPENDIX A  
IRB DOCUMENTATION 
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Instructions and Notes: 
 Depending on the nature of what you are doing, some sections may not be applicable to your research. If so mark as “NA”.  
 When you write a protocol, keep an electronic copy. You will need to modify this copy when making changes. 
 
 
1 Protocol Title 
Include the full protocol title: Wearable Robot for Load Carrying Assistance 
 
 
2 IRB Review History 
If you have submitted this protocol for review by an external IRB, provide the previous study identification number and 
provide details of the review including the IRB name, date of review, and IRB contact information. 
 
 
3 Background and Objectives 
Provide the scientific or scholarly background for, rationale for, and significance of the research based on the existing 
literature and how will it add to existing knowledge. 
 Describe the purpose, specific aims, or objectives. 
 State the hypotheses to be tested. 
 Describe the relevant prior experience and gaps in current knowledge. 
 Describe any relevant preliminary data. 
The objective of the proposed investigation is to collect data from two environments; over ground and on a 
treadmill. Heart rate, speed, and distance will be collected in the over ground trials and in addition VO2 for 
treadmill trials. The purpose of the device is to decrease metabolic cost and therefore increase walking 
speed, stamina and/or increase distance traveled.  The device uses a linear rail system to oscillate the 
mass of the pack, 0.5-1in, in phase with the user as they walk in order to reduce required forces and 
energy for walking.  The primary purpose of this pilot study is to determine the effectiveness of the device. 
 
 
 
 
 
4 Inclusion and Exclusion Criteria 
Describe the inclusion and the exclusion criteria for the study. 
 
Describe how individuals will be screened for eligibility. 
 
How many participants do plan to enroll into the study?  
 Provide a rationale for the proposed enrollment number 
 What percentage of screened individuals will likely qualify for the study?  
 
Indicate if you are specifically recruiting individuals of the following populations as participants.  If this is the case, these 
populations must be indicated in your inclusion criteria.   
 Adults unable to consent 
 Pregnant Women 
 Individuals who are not yet adults  (individuals who are under age 18) 
 Native Americans 
The test subjects that will be used in the proposed investigation will be comprised of individuals 
that are physically capable of walking 800 meters with a pack that weighs 35-45lbs who and are 
in good health. 
 
INCLUSION CRITERIA 
1. Between the ages of 18-45 years of age 
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2.  Can walk a distance of 800 meters with 45lb pack in multiple trials 
3. Full range of limbs including arms, knees, legs and hips 
4. Ability to wear test equipment and heart rate monitors 
5.  Ability to follow simple instructions 
6. Must have proof of medical insurance 
7.  Must answer no to all of the questions in the Par-Q questionnaire 
 
EXCLUSION CRITERIA 
1. Excessive body mass or lack of stamina 
2. Restricted joint movement in arms and legs 
3. Inability to meet inclusion criteria 
4. Any previous medical conditions involving the heart 
 
Eight to ten individuals will be screened for eligibility and 5-10 individuals will be enrolled in 
the study. This pilot study is to determine if wearing the device turned on (with the30 lb 
additional load oscillating in phase with the user) versus the device turned off ( 22lb additional 
load is static) increases walking speed, stamina and walking distance and decreases heart rate.  
The participants in the proposed study will be comprised of individuals that are capable of 
performing the tests and are in good health. 
 
Excessive body mass will be defined as a Body Mass Index greater than 30 which is considered obese. 
 
Screening Tools will include the Par-Q questionnaire and the determination of the BMI Index 
 
 
 
 5 Recruitment Methods 
 Describe when, where, and how potential participants will be identified and recruited. 
 Describe materials that will be used to recruit participants. (Attach copies of these documents with the 
application.) 
Test subjects will be recruited from within Arizona State University’s student body who meet the 
physical requirements. Test subjects will be evaluated based on their physical abilities and 
information they provide to the research staff.  
 
As part of the screening process, test subjects will be required to sign a consent form indicating 
they have been fully briefed on all of the possible physical dangers associated with the testing 
and the entire testing protocol. 
 
A recruiting statement is given in a separate file. 
 
 
6 Study Timelines 
Describe: 
 The duration of an individual participant’s participation in the study. 
 The duration anticipated to enroll all study participants. 
 The estimated date for the investigators to complete this study (up to and including primary analyses). 
Testing will be conducted over 5-10 days, one day for each subject, and will last approximately 4 
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hours. 
 
The study will be finished by December 2014. 
 
 
7 Procedures Involved 
Describe and explain the study design. Provide a description of all research procedures being performed and when they are 
performed. Describe procedures including: 
 The documents/ measures / devices/ records /sampling that will be used to collect data about participants. (Attach 
all surveys, scripts, and data collection forms.) 
 What data will be collected including long-term follow-up.  
 All drugs and medical devices used in the research and the purpose of their use, and their regulatory approval 
status. 
A protocol is submitted as part of the package. 
 
Device training will consist of a 10 minute information session in the robotics lab on how the 
device works, what to expect and how to use the controls. After this period, the subject will be 
allowed to try the device at their own pace in the robotics lab for 5-10 minutes. 
 
After the subject is comfortable with the device, we will then commence testing on the treadmill. 
The tests are listed below, but in order to insure independent results, we will use a statistics 
software which will randomize trials and levels. The subject will be allowed to rest 10-15 
minutes and we will perform 4 tests on the treadmill. 
 Test subjects will first walk 800 meters at 3mph with the device turned off and a 22lb payload 
(to account for the weight of the device) and then be allowed to rest 10-30 minutes depending 
on subject’s stamina. 
 Test subjects will then walk 800 meters at 3mph with the device turned on and a 30lb payload 
and then be allowed to rest 10-30 minutes depending on stamina. 
 If and only if the subjects feel able to do so, the previous two tests will be repeated with 10-30 
minute breaks between them. 
 The order of testing device on versus device off will be randomized 
 Subjects will wear a heart rate monitor and a V02 mask 
 Resting heart rate and resting V02 rate will be collected before each of the 4 trials.  This resting 
V02 rate will set the baseline for each trial. 
The subject will then have the opportunity to rest a minimum of half an hour up to an hour and 
then we will go to either the campus athletic track or the SRC, depending on availability, to 
begin over ground testing.  Again, the trials as presented are not randomized but will be when the 
subject performs them. There will be the same 4 tests performed. 
 Test subjects will first walk 800 meters with the device turned off and a 22lb payload (to account 
for the weight of the device). They will then be allowed to rest 10-30 minutes depending on 
subject’s stamina. 
 Test subjects will then walk 800 meters with the device turned on and a 30lb payload. They will 
then be allowed to rest 10-30 minutes depending on stamina. 
 If and only if the subjects feel able to do so, the previous two tests will be repeated with 10-30 
minute breaks between them. 
 For each test, a heart rate monitor and a GPS watch will be worn to measure heart rate, speed, 
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and time during the test. 
While performing all tests, the subjects will be monitored for their heart rate via a wireless 
Bluetooth heart rate wrist watch. For over ground testing, the watch will also track subjects 
speed and distance walked. If the subject is comfortable and able, we will repeat the tests to get 
more iterations. The subject can stop any test at any time if they do not wish to continue.  
 
 
 
 
 
8 Withdrawal of Participants 
Describe anticipated circumstances under which participants will be withdrawn from the research without their consent. 
 
Describe procedures that will be followed when participants withdraw from the research, including partial withdrawal from 
procedures with continued data collection. 
Taking part in this research study is strictly voluntary. A subject may choose not to take part in 
this research study or may withdraw their consent at any time. The commitment of the research 
staff is to provide help and assistance and will not at any time be affected by an individual’s 
choice not to participate. If subjects decide to end their participation in the study, they will not 
complete any additional testing nor will they be asked to continue testing. There will be no 
penalty or loss of benefits if the subjects decide to end testing prematurely. 
 
If the participant is tired and does not want to continue, they can withdrawal at any time. 
 
If their heart rate goes above the maximum level, the heart rate monitor will beep and you will be 
asked to stop. 
 
From CDC, “This maximum rate is based on the person's age. An estimate of a person's 
maximum age-related heart rate can be obtained by subtracting the person's age from 220. For 
example, for a 50-year-old person, the estimated maximum age-related heart rate would be 
calculated as 220 - 50 years = 170 beats per minute (bpm).” 
 
 
9 Risks to Participants 
List the reasonably foreseeable risks, discomforts, hazards, or inconveniences to the 
participants related the participants’ participation in the research. Include as may be useful for 
the IRB’s consideration, the probability, magnitude, duration, and reversibility of the risks. 
Consider physical, psychological, social, legal, and economic risks. Reference this information 
when appropriate. 
 If applicable, indicate which procedures may have risks to an embryo or fetus should 
the participant be or become pregnant. 
 If applicable, describe risks to others who are not subjects. 
1. Physical risks associated with walking with a 35-45lb pack such as tripping and falling 
either due to the motion of the device causing the subject to lose balance. 
2. Physical risks associated with carrying a 35-45lb pack such as fatigue in legs, and lower 
back. 
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3. There is a chance for the battery to overheat and catch fire. 
4. There is a chance of tripping and falling and breaking a bone. 
 
To minimize potential risks, the subject will have a training session to familiarize themselves 
with the device that is closely supervised by a member of the team which will allow them to feel 
how the device will affect their walking. Before testing begins, the subject will be asked to 
stretch to reduce the possibility of strained or pulled muscles. The battery will be placed in a 
fireproof bag, seen in Figure 2, which will contain any fire that may occur. 
The subject will be asked to wear a heart rate monitor. If their heart rate goes above the 
maximum level, the heart rate monitor will beep and you will be asked to stop. 
 
From CDC, “This maximum rate is based on the person's age. An estimate of a person's 
maximum age-related heart rate can be obtained by subtracting the person's age from 220. For 
example, for a 50-year-old person, the estimated maximum age-related heart rate would be 
calculated as 220 - 50 years = 170 beats per minute (bpm).” 
 
Participation in this study may cause all or some of the side effects listed above. There is in 
addition always the risk of developing previously unknown side effects.  
 
If mild side effects or discomforts do occur, the research staff will attempt to minimize these 
effects by asking you to rest. If any serious side effects occur, the research staff will attempt to 
minimize these by directing you to the emergency room. 
 
If there are any major side effects, the research staff will call 911 immediately. The investigator 
is willing to discuss any questions you might have about these risks and discomforts. 
 
As stated in the protocol, the battery will be placed in a fireproof bag for safety. 
 
All participants will wear shoes (not sandals). 
 
 
 
 
 
10 Potential Benefits to Participants 
Realistically describe the potential benefits that individual subjects may experience from taking 
part in the research. Include the probability, magnitude, and duration of the potential benefits. 
 
Indicate if there is no direct benefit. Do not include benefits to society or others. 
Although we know of no known benefits to you, we anticipate that this research will assist in 
developing a useful product that may have several military applications. 
  
Your participation will be of no direct benefit to you and you have the right to refuse to 
participate in this study. 
 
 
 
11 Vulnerable Populations 
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If the research involves individuals who are vulnerable to coercion or undue influence, describe 
additional safeguards included to protect their rights and welfare. 
 If the research involves pregnant women, review “CHECKLIST: Pregnant Women (HRP-412)” to ensure that you 
have provided sufficient information. 
 If the research involves persons who have not attained the legal age for consent to treatments or procedures 
involved in the research (“children”), review the “CHECKLIST: Children (HRP-416)” to ensure that you have 
provided sufficient information. 
 If the research involves cognitively impaired adults, review “CHECKLIST: Cognitively Impaired Adults (HRP-417)” 
to ensure that you have provided sufficient information. 
 
NA 
 
 
 
 
 
 
12 Setting 
Describe the sites or locations where your research team will conduct the research. 
 Identify where research procedures will be performed. 
 For research conducted outside of the ASU  describe: 
o Site-specific regulations or customs affecting the research. 
o Local scientific and ethical review structures in place. 
 
All trials will be conducted on the Polytechnic Campus of Arizona State University within the 
robotics research lab, in the Student Recreational Center in a designated area, or on the campus 
sports track located outside the Student Recreational Center 
 
13 Multi-Site Research 
If this is a multi-site study where you are the lead investigator, describe the processes you will use to ensure communication 
among sites, such as: 
 Each site has the most current version of the protocol, consent document, and HIPAA authorization. 
 Required approvals have been obtained at each site (including approval by the site’s IRB of record). 
 Describe processes you will use to communicate with participating sites. 
 Participating sites will safeguard data as required by local information security policies. 
 Local site investigators conduct the study appropriately. 
  
NA 
 
14 Sharing of Results with Participants 
Describe whether results (study results or individual participant results, such as results of genetic tests or research findings) 
will be shared with participants or others (e.g., the participant’s primary care physicians) and if so, describe how it will be 
shared. 
 
Data will only be shared with individuals once the study has been completed. 
 
 
15 Resources Available 
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Describe the qualifications (e.g., training, experience, oversight) of you and your staff as required to perform your roles. 
When applicable describe knowledge of the local study sites, culture, and society. Provide enough information to convince 
the IRB that you have qualified staff for the proposed research. 
Describe other resources available to conduct the research: For example, as appropriate: 
 Describe your facilities. 
 Describe the availability of medical or psychological resources that participants might need as a result of any 
anticipated consequences of the human research. 
 Describe your process to ensure that all persons assisting with the research are adequately informed about the 
protocol, the research procedures, and their duties and functions. 
 
There is the Gilbert Hospital next to campus 
56 South Power Road 
Gilbert, AZ 85295 
(480) 984-2000 
16 Prior Approvals 
Describe any approvals that will be obtained prior to commencing the research. (E.g., school, external site, funding agency, 
laboratory, radiation safety, or biosafety approval.) 
 
NA 
17 Privacy 
Describe the steps that will be taken to protect subjects’ privacy interests. “Privacy interest” refers to a person’s ability to 
place limits on who they interact or who can have access to personal information they provide. 
 
 
Describe what steps you will take to make the subjects feel at ease with the research situation in terms of the nature of 
questions being asked and the procedures being performed. “At ease” does not refer to physical discomfort, but the sense 
of intrusiveness a subject might experience in response to questions, examinations, and procedures. 
 
 
Indicate how the research team is authorized to access any sources of information about the participants. 
 
We will collect data on the age, height, weight of the individual and record their heart rates and 
duration of the tests and VO2 results. 
Andrew and Chase will sign the privacy statement attached. 
18 Data Management and Confidentiality 
Describe the data analysis plan, including procedures for statistical analysis. 
 
Describe the steps that will be taken to secure the data during storage, use, and transmission.  
 Training, authorization of access, password protection, encryption, physical controls, certificates of confidentiality, 
and separation of identifiers and data  
 
Describe how data and any specimens will be handled: 
 What personal identifiers will be included in that data or associated with the specimens? 
 Where and how data or specimens will be stored? 
 How long the data or specimens will be stored? 
 Who will have access to the data or specimens? 
 Who is responsible for receipt or transmission of the data or specimens? 
 How will data and specimens be transported? 
 If data or specimens will be banked for future use, describe where the specimens will be stored, how long they will 
be stored, how the specimens will be accessed, and who will have access to the specimens. 
 Describe the procedures to release data or specimens, including: the process to request a release, approvals 
required for release, who can obtain data or specimens, and the data to be provided with specimens. 
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All data, videos, and photographs will be modified as to not contain any information relating to 
the subjects identity. All data, video, and photographs and will be kept in a locked storage 
cabinet and all unused data, video, and photographs will be destroyed two years after testing is 
concluded. It is estimated that the documents will be destroyed January 1, 2015. All data about 
the subjects will not include any names, addresses, or other identifying information. 
 
19 Safety Monitoring 
This is required when research involves more than Minimal Risk to participants. The plan might include establishing a data 
monitoring committee and a plan for reporting data monitoring committee findings to the IRB and the sponsor.  Describe: 
 The plan to periodically evaluate the data collected regarding both harms and benefits to determine whether 
participants remain safe. 
 What data are reviewed, including safety data, untoward events, and efficacy data? 
 How the safety information will be collected (e.g., with case report forms, at study visits, by telephone calls with 
participants). 
 Who will review the data? 
 
NA 
20 Compensation and Costs  
Describe the available compensation (monetary or credit that will be provided to research participants). 
 
Describe any costs that participants may be responsible for because of participation in the research. 
 
No compensation will be given 
 
21 Consent Process 
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Indicate how you will be obtaining consent. Describe: 
 Where will the consent process will take place 
 Any waiting period available between informing the prospective participant and obtaining the consent. 
 Any process to ensure ongoing consent. 
 Whether you will be following “SOP: Informed Consent Process for Research (HRP-090).” If not, describe: 
o The role of the individuals listed in the application as being involved in the consent process. 
o The time that will be devoted to the consent discussion. 
o Steps that will be taken to minimize the possibility of coercion or undue influence. 
o Steps that will be taken to ensure the participants’ understanding. 
 
Non-English Speaking Participants 
 Indicate what language(s) other than English are understood by prospective participants or representatives. 
 If participants who do not speak English will be enrolled, describe the process to ensure that the oral and written information 
provided to those participants will be in their language. Indicate the language that will be used by those obtaining consent. 
 
Waiver or Alteration of Consent Process (consent will not be obtained, required information will not be disclosed, or the research involves 
deception) 
 Review the “CHECKLIST: Waiver or Alteration of Consent Process (HRP-410)” to ensure you have provided sufficient 
information for the IRB to make these determinations. 
 
Participants who are not yet adults (infants, children, teenagers) 
 Describe the criteria that will be used to determine whether a prospective participant has not attained the legal age for consent 
to treatments or procedures involved in the research under the applicable law of the jurisdiction in which the research will be 
conducted. (E.g., individuals under the age of 18 years.) 
 Describe whether parental permission will be obtained from: 
o Both parents unless one parent is deceased, unknown, incompetent, or not reasonably available, or when only one 
parent has legal responsibility for the care and custody of the child. 
o One parent even if the other parent is alive, known, competent, reasonably available, and shares legal responsibility 
for the care and custody of the child. 
 Describe whether permission will be obtained from individuals other than parents, and if so, who will be allowed to provide 
permission. Describe the process used to determine these individuals’ authority to consent to each child’s general medical 
care. 
 Indicate whether assent will be obtained from all, some, or none of the children. If assent will be obtained from some children, 
indicate which children will be required to assent. 
 When assent of children is obtained describe whether and how it will be documented. 
 
Cognitively Impaired Adults 
 Describe the process to determine whether an individual is capable of consent. The IRB allows the person obtaining assent to 
document assent on the consent document and does not routinely require assent documents and does not routinely require 
children to sign assent documents. 
 
Adults Unable to Consent 
 List the individuals from whom permission will be obtained in order of priority. (E.g., durable power of attorney for health care, 
court appointed guardian for health care decisions, spouse, and adult child.) 
o For research conducted in the state, review “SOP: Legally Authorized Representatives, Children, and Guardians 
(HRP-013)” to be aware of which individuals in the state meet the definition of “legally authorized representative.” 
o For research conducted outside of the state, provide information that describes which individuals are authorized 
under applicable law to consent on behalf of a prospective participant to their participation in the procedure(s) 
involved in this research. One method of obtaining this information is to have a legal counsel or authority review 
your protocol along the definition of “legally authorized representative” in “SOP: Legally Authorized 
Representatives, Children, and Guardians (HRP-013).” 
 Describe the process for assent of the participants. Indicate whether: 
o Assent will be required of all, some, or none of the participants. If some, indicated, which participants will be 
required to assent and which will not. 
o If assent will not be obtained from some or all participants, an explanation of why not. 
o Describe whether assent of the participants will be documented and the process to document assent. The IRB 
allows the person obtaining assent to document assent on the consent document and does not routinely require 
assent documents and does not routinely require participants to sign assent documents. 
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The research staff will provide a consent form for each subject. The subjects will be required to 
read, understand, and sign the consent form. All known risks and benefits will be discussed with 
the subject verbally and also included on consent form. An unsigned copy of the consent form 
may be mailed to the potential subject prior to testing so they may have the time to study it and 
discuss it with their family or friends before making the decision. 
 
Dr Sugar will get informed consent from the individuals 
 
A consent form has been attached. 
 
 
 
22 Process to Document Consent in Writing 
Describe whether you will be following “SOP: Written Documentation of Consent (HRP-091).” If not, describe whether and 
how consent of the participant will be documented. 
 
If your research presents no more than minimal risk of harm to participants and involves no procedures for which written 
documentation of consent is normally required outside of the research context, the IRB will generally waive the requirement 
to obtain written documentation of consent. 
 
(If you will document consent in writing, attach a consent document. If you will obtain consent, but not document consent in 
writing, attach a consent script. Review “CHECKLIST: Waiver of Written Documentation of Consent (HRP-411)” to ensure 
that you have provided sufficient information. You may use “TEMPLATE CONSENT DOCUMENT (HRP-502b)”to create the 
consent document or script.) 
 
Dr Sugar will get informed consent from the individuals 
 
A consent form has been attached. 
 
 
 
 
23 Sharing of Results with Participants 
If the drug is investigational (has an IND) or the device has an IDE or a claim of abbreviated IDE (non-significant risk 
device), include the following information: 
 Identify the hold of the IND/IDE/Abbreviated IDE. 
 Explain procedures followed to comply with FDA sponsor requirements for the following: 
 
 Applicable to: 
FDA Regulation IND Studies IDE studies 
Abbreviated IDE 
studies 
21 CFR 11 X X  
21 CFR 54 X X  
21 CFR 210 X   
21 CFR 211 X   
21 CFR 312 X   
21 CFR 812  X X 
21 CFR 820  X  
 
 
NA 
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24 CITI 
Provide the date that the members of the research team have taken the CITI training for human participants.  This training 
must be taken within the last 3 years. Additional information can be found at: 
http://researchintegrity.asu.edu/training/humans 
 
Dr. Thomas Sugar – completion 3/8/2011 
 
 
 
 
 
 
 
 
 
  
  54 
Consent Form: Bioscience 
 
Title of research study: Wearable Robot for Load Carrying Assistance 
 
Investigator: Dr. Thomas Sugar 
 
Why am I being invited to take part in a research study? 
We invite you to take part in a research study because we are determining the effectiveness of a 
load carrying assistance device. 
 
Why is this research being done? 
Dr. Thomas G. Sugar and his student are designing a load carrying assistance device which has 
the potential to significantly reduce the energy needed to carry heavy loads long distances. A 
device such as this could have potential benefit to the military where soldiers are required to 
carry 90lb+ rucksacks.  
 
How long will the research last? 
We expect that individuals will spend about 4 hours on a single day participating in the proposed 
activities. 
 
How many people will be studied? 
We expect 5-10 people to participate in this research study. 
 
What happens if I say yes, I want to be in this research? 
It is up to you to decide whether or not to participate. 
If you decide to participate, as a study participant you will join a study involving research of a 
powered wearable robot device to assist load carrying. 
Your participation will last for one day at the Human and Machine Integration Laboratory at the 
Polytechnic Campus of Arizona State University in Mesa, Arizona. 
You will interact with three people involved in the research study, Dr. Thomas Sugar, Mr. Chase 
Wheeler and Mr. Andrew Bates. 
You will be asked to come to the Polytechnic Campus of Arizona State University to perform the 
tests. The testing day will last for 4 hours which includes a 10 minute training session, a 10 
minute period of familiarization with the device, followed by 8 tests with resting time between 
the tests. The schedule is as follows: 
1. You will go through a 10 minute training demonstration of how the device works and 
how to use it.  
2. You will then have the opportunity to wear the device for 5-10 minutes to familiarize 
yourself with the controls and how the device affects how you walk. 
3. We will then commence testing on the treadmill. You will be allowed to rest 10-30 
minutes and we will perform four tests on a treadmill. 
4. You will put on a heart rate monitor and mask that measures VO2 and first walk 800 
meters at approximately 3mph with the device turned off and a 22lb payload. You will 
then be allowed to rest 10-30 minutes depending on your stamina and how you feel. 
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5. You will put on a heart rate monitor and mask that measures VO2 .  Test subjects will 
then walk 800 meters at approximately 3mph with the device turned on and a 30lb 
payload and then be allowed to rest 10-30 minutes depending on stamina. 
6. If and only if you feel able to do so, we will repeat the previous two tests with 10-30 
minute breaks in between. 
7. We will then walk to the Student Recreation Center or campus sports track, depending on 
availability, and you will first walk 800 meters with the device turned off and a 22lb 
payload. You will then be allowed to rest 10-30 minutes depending on your stamina and 
how you feel.  A heart rate monitor will be worn and walking speed and time will be 
recorded. 
8.  You will then walk 800 meters with the device turned on and a 30lb payload. You will 
then be allowed to rest 10-30 minutes depending on your stamina and how you feel.  A 
heart rate monitor will be worn and walking speed and time will be recorded. 
9. If and only if you feel able to do so, we will repeat the previous two tests with 10-30 
minute breaks in between. 
10. After completing the tests you will be asked to give your feedback on the device. 
Some people will walk with the device turned on first and some will walk with the device turned 
off first.  A random order will be generated by the team. 
Before each test begins, a resting heart rate and a resting metabolic rate will be measured. 
 
What happens if I say yes, but I change my mind later? 
You can leave the research at any time and it will not be held against you. 
If you decide to leave the research there will be no adverse consequences, and no one will try to 
convince you otherwise or change your mind. If you decide to leave the research, contact the 
investigator so that the investigator can prepare for another candidate. 
 
Is there any way being in this study could be bad for me? 
There are certain risks and discomforts that may be associated with this research. They include 
but are not limited to: 
1. Physical risks associated with walking with a 35-45lb pack such as tripping and falling 
either due to the motion of the device causing the subject to lose balance. 
2. Physical risks associated with carrying a 35-45lb pack such as fatigue in legs, and lower 
back. 
3. There is a chance for the battery to overheat and catch fire. 
4. There is a chance of tripping and falling and breaking a bone. 
 
To minimize potential risks, the subject will have a training session to familiarize themselves 
with the device that is closely supervised by a member of the team which will allow them to feel 
how the device will affect their walking. Before testing begins, the subject will be asked to 
stretch to reduce the possibility of strained or pulled muscles. The battery will be placed in a 
fireproof bag which will contain any fire that may occur. 
The subject will be asked to wear a heart rate monitor. If their heart rate goes above the 
maximum level, the heart rate monitor will beep and you will be asked to stop. 
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From CDC, “This maximum rate is based on the person's age. An estimate of a person's 
maximum age-related heart rate can be obtained by subtracting the person's age from 220. For 
example, for a 50-year-old person, the estimated maximum age-related heart rate would be 
calculated as 220 - 50 years = 170 beats per minute (bpm).” 
 
Participation in this study may cause all or some of the side effects listed above. There is in 
addition always the risk of developing previously unknown side effects.  
 
If mild side effects or discomforts do occur, the research staff will attempt to minimize these 
effects by asking you to rest. If any serious side effects occur, the research staff will attempt to 
minimize these by directing you to the emergency room. 
 
If there are any major side effects, the research staff will call 911 immediately.  
 
The investigator is willing to discuss any questions you might have about these risks and 
discomforts. 
 
What happens to the information collected for the research? 
Efforts will be made to limit the use and disclosure of your personal information, including this 
research study, to people who have a need to review this information. 
 
What else do I need to know? 
If you agree to participate in the study, then consent does not waive any of your legal rights. 
However, no funds have been set aside to compensate you in the event of injury. 
If mild side effects or discomforts do occur, the research staff will attempt to minimize these 
effects by asking you to rest. If any serious side effects occur, the research staff will attempt to 
minimize these by directing you to the emergency room. 
 
Who can I talk to? 
If you have questions, concerns, or complaints or think the research has hurt you, talk to the 
research team: Dr. Thomas Sugar at 480-727-1127. 
This research has been reviewed and approved by the Bioscience IRB (“IRB”). You may talk to 
them at 480-965-6788 or research.integrity@asu.edu if: 
 Your questions, concerns or complaints are not being answered by the research team 
 You cannot reach the research team 
 You want to talk to someone besides the research team 
 You have questions about your rights as a research participant 
 You want to get information or provide input about this research 
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Signature Block for Capable Adult 
Your signature documents your permission to take part in this research. 
 
___________________________________________________ 
 __________________________ 
       Signature of Participant               Date 
___________________________________________________  
       Printed Name of Participant  
___________________________________________________ 
 __________________________ 
        Signature of Person Obtaining Consent              Date 
___________________________________________________  
              Printed Name of Person Obtaining Consent 
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Training Session 
 
Description of Device and How the Device Works(3 min): 
The device is a backpack with a linear carriage that oscillates based on the motion of the human 
being. There is an accelerometer in the waist belt that measures the motion of your trunk as you 
walk which is fed to a microcontroller that manipulates the signal and controls the position of the 
linear carriage. The device oscillates 0.5 inches only if the user is activating a switch on a 
joystick. The device is powered by a lithium polymer battery. 
 
Demonstration of How to Put On and Adjust the Pack(2 min): 
One of the team members will show the subject how to put on and adjust the pack to where it is 
comfortable. 
 
Trial (5 min): 
The subject will then put on the backpack, adjust it for comfort and turn the device on to feel 
how the device will affect how they walk. 
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Wearable Robot for Load Carrying Assistance 
 
Date    _____________________ 
 
Subject ID Number  _____________________ 
 
Age: ________ Circle: Male / Female  Weight ______________ 
 
Resting Heart Rate ___________________ 
 
 
1. Treadmill Test    Circle: Device Off  Device On 
a. Heart Rate at beginning of Test  _____________ 
b. Heart Rate at end of Test  _____________ 
c. Duration of Test (seconds)  _____________  seconds 
d. Attach COSMED Metabolics Print Out 
 
2. Rest 10-30 minutes 
 
3. Treadmill Test  Circle: Device Off  Device On 
a. Heart Rate at beginning of Test  _____________ 
b. Heart Rate at end of Test  _____________ 
c. Duration of Test (seconds)  _____________  seconds 
d. Attach COSMED Metabolics Print Out 
 
4. Rest 10-30 minutes 
 
5. Treadmill Test   Circle: Device Off  Device On 
a. Heart Rate at beginning of Test  _____________ 
b. Heart Rate at end of Test  _____________ 
c. Duration of Test (seconds)  _____________  seconds 
d. Attach COSMED Metabolics Print Out 
 
6. Rest for 10-30 minutes 
 
7. Treadmill Test    Circle: Device Off  Device On 
a. Heart Rate at beginning of Test  _____________ 
b. Heart Rate at end of Test  _____________ 
c. Duration of Test (seconds)  _____________  seconds 
d. Attach COSMED Metabolics Print Out 
 
8. Rest for 10-30 minutes 
 
9. Over Ground Test    Circle: Device Off  Device On 
a. Heart Rate at beginning of Test  _____________ 
  61 
b. Heart Rate at end of Test  _____________ 
c. Duration of Test (seconds)  _____________  seconds 
 
10. Rest 10-30 minutes 
 
11. Over ground Test    Circle: Device Off  Device On 
a. Heart Rate at beginning of Test  _____________ 
b. Heart Rate at end of Test  _____________ 
c. Duration of Test (seconds)  _____________  seconds 
 
12. Rest 10-30 minutes 
 
13. Over Ground Test  Circle: Device Off  Device On 
a. Heart Rate at beginning of Test  _____________ 
b. Heart Rate at end of Test  _____________ 
c. Duration of Test (seconds)  _____________  seconds 
 
14. Rest for 10-30 minutes 
 
15. Over Ground Test    Circle: Device Off  Device On 
a. Heart Rate at beginning of Test  _____________ 
b. Heart Rate at end of Test  _____________ 
c. Duration of Test (seconds)  _____________  seconds 
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APPENDIX B  
SIMULATED VERSUS ACTUAL CONTROL SIGNALS 
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𝑥𝑝𝑜𝑔𝑜 = 0.0254 sin (𝜙 −
𝑝𝑖
4
). 
  
𝑥𝑝𝑜𝑔𝑜 = 0.0254cos 𝜙 
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𝑥𝑝𝑜𝑔𝑜 = −0.0254cos 𝜙 
  
𝑥𝑝𝑜𝑔𝑜 = 0.0254𝑠𝑖𝑛 𝜙 
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𝑥𝑝𝑜𝑔𝑜 = −0.0254𝑠𝑖𝑛 𝜙 
  
 
 
